Illumina, Inc. (NASDAQ:ILMN) Q1 2024 Earnings Call Transcript
Illumina, Inc. misses on earnings expectations. Reported EPS is $-0.79245 EPS, expectations were $0.03. Illumina, Inc.
Illumina Inc. (ILMN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | GuardCap Asset Management Guardian Capital | 2,126,797.332 | $284,097,091 | +2% | 3.48% |
| 2. | Citadel Investment Group Ken Griffin | 1,165,123.892 | $155,636,977 | +166% | 0.03% |
| 3. | Select Equity Group Robert Joseph Caruso | 1,136,114.76 | $151,761,944 | -26% | 0.53% |
| 4. | Corvex Capital Keith Meister | 1,032,942.624 | $137,980,235 | +38% | 6.39% |
| 5. | Rima Senvest Management Richard Mashaal | 804,211.596 | $107,426,397 | +20% | 4.11% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $137.18 | 692 | Officer, Director | 14,861 | 2024-02-22 | Filing | |
| $135.69 | 1,553 | Officer, Director | 14,169 | 2024-02-22 | Filing | |
| $134.91 | 5,085 | Officer, Director | 12,616 | 2024-02-22 | Filing | |
| $43.87 | 315 | Director | 670 | 2012-04-18 | Filing | |
| $36.54 | 809 | Director | 809 | 2012-01-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $112.84 | 315 | Officer | 8,314 | 2023-11-07 | Filing | |
| $167.04 | 500 | Officer | 45,524 | 2023-08-22 | Filing | |
| $190.08 | 500 | Officer | 46,022 | 2023-07-24 | Filing | |
| $200.00 | 500 | Officer | 46,522 | 2023-06-22 | Filing | |
| $209.67 | 1,676 | Officer | 47,022 | 2023-05-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 18,687,511.364 | $2,531,176,150 | 0.05% | |
| 2. | 13,675,482.972 | $1,852,309,607 | 0.04% | |
| 3. | 7,071,092.86 | $957,761,644 | 2.76% | |
| 4. | 6,911,877.248 | $936,196,292 | 0.04% | |
| 5. | 5,423,490.532 | $734,598,076 | 0.6% |
News See All
14 Best Medical Device Stocks To Buy Now
In this article, we will discuss the 14 Best Medical Device Stocks To Buy Now.
Hedge Funds and Insiders Are Buying These 5 Stocks
This article presents an overview of Hedge Funds and Insiders Are Buying These 5 Stocks. For a detailed overview of such stocks, read our article, Hedge Funds and Insiders Are Buying These 10 Stocks...
10 Biggest Stocks Targeted By Activist Investors Right Now
In this article, we're going to take a look at 10 biggest stocks targeted by activist investors right now.
Reasons for the Decline of Illumina (ILMN)
Baron Funds, an investment management company, released its “Baron Opportunity Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Do You Believe in the Growth Prospects of Illumina (ILMN)?
RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark Large Growth Fund” fourth quarter 2023 investor letter.
15 Best Shareholder Activism Law Firms
In this article, we discuss the 15 Best Shareholder Activism Law Firms.
Illumina, Inc. (NASDAQ:ILMN) Q4 2023 Earnings Call Transcript
Illumina, Inc. beats earnings expectations. Reported EPS is $0.14, expectations were $0.01. Illumina, Inc.
Jim Cramer is Bearish on These 5 Stocks
Jim Cramer was recently asked about his thoughts on Robinhood Markets Inc (NASDAQ:HOOD). Cramer said Robinhood Markets Inc's (NASDAQ:HOOD) platform has "too much exposure" to options and Bitcoin.
Illumina (ILMN) Leads the Market With 80% Share
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.